Clinical Trials Directory

Trials / Completed

CompletedNCT01283230

Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography

Prospective Cohort Study for Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography in Patients With Chronic Liver Disease and Healthy Liver/Kidney Donors

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a prospective cohort Study for evaluation of liver fibrosis staging with acoustic radiation force impulse elastography in patients with chronic liver disease and healthy liver/kidney donors.

Detailed description

A recent new method for liver fibrosis assessment based on similar technology to transient elastography is acoustic radiation force impulse (ARFI) imaging. ARFI has the advantages which can be conducted in parallel ways of measuring points in the patients with chronic liver disease when they underwent routine ultrasound examination. Thus, the aim of this study was to identify the normal range of ARFI velocity and assess the best cut-off value by recruiting healthy living liver and kidney donors.

Conditions

Interventions

TypeNameDescription
DEVICEAcoustic radiation force impulse imagingAcoustic radiation force impulse (ARFI) imaging were measured 10 times in each patient.The region of interest was chosen in an area where the normal liver parenchyma was at least 6 cm thick and free of large blood vessels was chosen. A measurement depth of 2 cm below the liver capsule was chosen to standardize the examination.

Timeline

Start date
2010-07-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-01-25
Last updated
2012-02-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01283230. Inclusion in this directory is not an endorsement.